Trial site
Hospital Universitari Dexeus
- 11running trials
- 5closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Triple-negative breast cancer3 trials
- Head and neck cancer2 trials
- Lung cancer2 trials
- Endometriosis1 trial
- Female infertility1 trial
- Gastric and oesophageal cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 26 trials
- Phase 36 trials
- Phase 1/21 trial
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Recruiting4 trials
- Not yet recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute3 trials
- MedSIR3 trials
- ALX Oncology Inc.2 trials
- Eli Lilly and Company2 trials
- Dizal Pharmaceuticals1 trial
- and 5 more
Running trials
Not yet recruiting
Optimizing the Use of Aspirin for the Prevention of Preeclampsia
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler
Recruiting
Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical Symptoms
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometriosis1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer
Terminated
Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer
Completed
Completed
Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer
Completed
First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC
Site data: ClinicalTrials.govUpdated 15 Nov 2026